AYTU logo

Aytu BioPharma (AYTU) Cash From Financing

Annual CFF

-$1.26 M
-$10.13 M-114.23%

June 30, 2024

Summary

Performance

1-Year Change

-114.23%

3-Year Change

-104.16%

5-Year Change

-106.62%

15-Year Change

-112.39%

AYTU Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

22.19%
AYTU annual cash flow from financing activities is higher than 22.19% of companies in Healthcare sector

High & Low

All-time High

$71.07 M
AYTU annual cash flow from financing activities is currently -101.78% below its historical high of $71.07 million

3-Year Low

-$1.26 M
AYTU annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
AYTU previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
AYTU next annual earnings announcement has not yet been scheduled

OtherAYTUcash flowmetrics:

Annual CFI

-$329.00 K
AYTU annual cash flow from investing activities is -$329.00 thousand

Annual CFO

-$1.39 M
AYTU annual cash flow from operations is -$1.39 million

Annual FCF

-$1.39 M
AYTU annual free cash flow is -$1.39 million

Annual CAPEX

-
AYTU annual capital expenditures value is unknown

Quarterly CFF

$911.00 K
-$157.00 K-14.70%

September 30, 2024

Summary

Performance

3-Month Change

-14.7%

1-Year Change

+133.32%

3-Year Change

+116.67%

5-Year Change

+114.24%

AYTU Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.96%
AYTU quarterly cash flow from financing activities is higher than 62.96% of companies in Healthcare sector

High & Low

All-time High

$68.18 M
AYTU quarterly cash flow from financing activities is currently -98.66% below its historical high of $68.18 million

3-Year Low

-$5.40 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AYTU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
AYTU next earnings announcement is scheduled for Feb 14, 2025

OtherAYTUcash flowmetrics:

Quarterly CFI

$381.00 K
AYTU quarterly cash flow from investing activities is $381.00 thousand

Quarterly CFO

-$1.19 M
AYTU quarterly cash flow from operations is -$1.19 million

Quarterly FCF

-$1.33 M
AYTU quarterly free cash flow is -$1.33 million

Quarterly CAPEX

$136.00 K
AYTU quarterly capital expenditures is $136.00 thousand

TTM CFF

$2.38 M
+$3.65 M+288.83%

September 30, 2024

Summary

Performance

3-Month Change

+288.83%

1-Year Change

+132.12%

3-Year Change

-91.18%

5-Year Change

-80.35%

AYTU TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

36.78%
AYTU TTM cash flow from financing activities is higher than 36.78% of companies in Healthcare sector

High & Low

All-time High

$86.71 M
AYTU TTM cash flow from financing activities is currently -97.25% below its historical high of $86.71 million

3-Year Low

-$7.73 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
AYTU previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 14, 2025
AYTU next earnings announcement is scheduled for Feb 14, 2025

OtherAYTUcash flowmetrics:

TTM CFI

$128.00 K
AYTU TTM cash flow from investing activities is $128.00 thousand

TTM CFO

-$2.37 M
AYTU TTM cash flow from operations is -$2.37 million

TTM FCF

-$2.50 M
AYTU TTM free cash flow is -$2.50 million

TTM CAPEX

$136.00 K
AYTU TTM capital expenditures is $136.00 thousand

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

AYTU Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-114.2%+133.3%+132.1%
3 y3 years-104.2%+116.7%-91.2%
5 y5 years-106.6%+114.2%-80.3%

AYTU Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-104.2%at low-93.3%+116.9%-88.4%+130.8%
5 y5-year-101.8%at low-98.7%+114.2%-97.3%+130.8%
alltimeall time-101.8%at low-98.7%+114.2%-97.3%+130.8%

Aytu BioPharma Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
-
$911.00 K(-14.7%)
$2.38 M(-288.8%)
Jun 2024
-$1.26 M(-114.2%)
$1.07 M(+101.5%)
-$1.26 M(-83.7%)
Mar 2024
-
$530.00 K(-520.6%)
-$7.73 M(+36.1%)
Dec 2023
-
-$126.00 K(-95.4%)
-$5.68 M(-23.4%)
Sep 2023
-
-$2.73 M(-49.4%)
-$7.42 M(-183.6%)
Jun 2023
$8.87 M(+479.8%)
-$5.40 M(-309.2%)
$8.87 M(-32.6%)
Mar 2023
-
$2.58 M(-238.5%)
$13.16 M(+8.8%)
Dec 2022
-
-$1.86 M(-113.8%)
$12.10 M(-41.1%)
Sep 2022
-
$13.56 M(-1313.7%)
$20.55 M(+1243.2%)
Jun 2022
$1.53 M(-95.0%)
-$1.12 M(-173.4%)
$1.53 M(-89.4%)
Mar 2022
-
$1.52 M(-76.9%)
$14.46 M(+121.0%)
Dec 2021
-
$6.59 M(-220.6%)
$6.54 M(-75.8%)
Sep 2021
-
-$5.46 M(-146.3%)
$27.03 M(-10.8%)
Jun 2021
$30.31 M(-57.3%)
$11.81 M(-284.7%)
$30.31 M(+150.0%)
Mar 2021
-
-$6.40 M(-123.6%)
$12.13 M(-86.0%)
Dec 2020
-
$27.08 M(-1343.2%)
$86.71 M(+25.9%)
Sep 2020
-
-$2.18 M(-65.8%)
$68.89 M(-3.1%)
Jun 2020
$71.07 M(+272.6%)
-$6.37 M(-109.3%)
$71.07 M(-8.4%)
Mar 2020
-
$68.18 M(+636.4%)
$77.56 M(+705.1%)
Dec 2019
-
$9.26 M(>+9900.0%)
$9.63 M(-49.5%)
Sep 2019
-
$0.00(-100.0%)
$19.07 M(0.0%)
Jun 2019
$19.08 M(-15.8%)
$116.50 K(-54.9%)
$19.07 M(+0.7%)
Mar 2019
-
$258.50 K(-98.6%)
$18.93 M(-38.8%)
Dec 2018
-
$18.70 M(<-9900.0%)
$30.92 M(+36.5%)
Jun 2018
$22.66 M(+122.4%)
-$23.70 K(-100.2%)
$22.66 M(-0.4%)
Mar 2018
-
$12.25 M(>+9900.0%)
$22.75 M(+83.3%)
Dec 2017
-
$0.00(-100.0%)
$12.41 M(-38.0%)
Sep 2017
-
$10.44 M(>+9900.0%)
$20.02 M(+96.5%)
Jun 2017
$10.19 M(-38.9%)
$62.10 K(-96.7%)
$10.19 M(-39.1%)
Mar 2017
-
$1.91 M(-74.9%)
$16.74 M(+11.6%)
Dec 2016
-
$7.61 M(+1152.9%)
$15.00 M(+21.0%)
Sep 2016
-
$607.20 K(-90.8%)
$12.39 M(-25.6%)
Jun 2016
$16.66 M(+34.9%)
$6.62 M(+3787.0%)
$16.66 M(+65.8%)
Mar 2016
-
$170.20 K(-96.6%)
$10.05 M(+1.7%)
Dec 2015
-
$5.00 M(+2.5%)
$9.88 M(+101.7%)
Sep 2015
-
$4.88 M
$4.90 M
DateAnnualQuarterlyTTM
Jun 2015
$12.35 M(>+9900.0%)
-
-
Feb 2015
-
$4500.00(-71.9%)
$46.20 K(-7.2%)
Nov 2014
-
$16.00 K(+540.0%)
$49.80 K(+27.0%)
Aug 2014
$39.20 K(-99.3%)
$2500.00(-89.2%)
$39.20 K(-9.0%)
Jun 2014
$5.24 M(>+9900.0%)
-
-
May 2014
-
$23.20 K(+186.4%)
$43.10 K(+31.8%)
Feb 2014
-
$8100.00(+50.0%)
$32.70 K(-7.6%)
Nov 2013
-
$5400.00(-15.6%)
$35.40 K(-10.4%)
Aug 2013
$39.50 K(+16.2%)
$6400.00(-50.0%)
$39.50 K(-13.6%)
May 2013
-
$12.80 K(+18.5%)
$45.70 K(+20.3%)
Feb 2013
-
$10.80 K(+13.7%)
$38.00 K(+9.5%)
Nov 2012
-
$9500.00(-24.6%)
$34.70 K(+2.4%)
Aug 2012
$34.00 K(-49.5%)
$12.60 K(+147.1%)
$33.90 K(+22.8%)
May 2012
-
$5100.00(-32.0%)
$27.60 K(-32.2%)
Feb 2012
-
$7500.00(-13.8%)
$40.70 K(-37.1%)
Nov 2011
-
$8700.00(+38.1%)
$64.70 K(-3.7%)
Aug 2011
$67.30 K(+77.6%)
$6300.00(-65.4%)
$67.20 K(+5.2%)
May 2011
-
$18.20 K(-42.2%)
$63.90 K(-10.1%)
Feb 2011
-
$31.50 K(+181.3%)
$71.10 K(+47.8%)
Nov 2010
-
$11.20 K(+273.3%)
$48.10 K(+27.2%)
Aug 2010
$37.90 K(+67.7%)
$3000.00(-88.2%)
$37.80 K(-10.6%)
May 2010
-
$25.40 K(+198.8%)
$42.30 K(+56.1%)
Feb 2010
-
$8500.00(+844.4%)
$27.10 K(+22.1%)
Nov 2009
-
$900.00(-88.0%)
$22.20 K(-1.8%)
Aug 2009
$22.60 K(-66.0%)
$7500.00(-26.5%)
$22.60 K(+20.2%)
May 2009
-
$10.20 K(+183.3%)
$18.80 K(+60.7%)
Feb 2009
-
$3600.00(+176.9%)
$11.70 K(+44.4%)
Nov 2008
-
$1300.00(-64.9%)
$8100.00(-87.8%)
Aug 2008
$66.50 K(+2670.8%)
$3700.00(+19.4%)
$66.50 K(+5.9%)
May 2008
-
$3100.00(>+9900.0%)
$62.80 K(+5.2%)
Feb 2008
-
$0.00(-100.0%)
$59.70 K(-1.5%)
Nov 2007
-
$59.70 K(>+9900.0%)
$60.60 K(+2425.0%)
Aug 2007
$2400.00
$0.00(0.0%)
$2400.00(0.0%)
May 2007
-
$0.00(-100.0%)
$2400.00(0.0%)
Feb 2007
-
$900.00(-40.0%)
$2400.00(+60.0%)
Nov 2006
-
$1500.00
$1500.00

FAQ

  • What is Aytu BioPharma annual cash flow from financing activities?
  • What is the all time high annual CFF for Aytu BioPharma?
  • What is Aytu BioPharma annual CFF year-on-year change?
  • What is Aytu BioPharma quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Aytu BioPharma?
  • What is Aytu BioPharma quarterly CFF year-on-year change?
  • What is Aytu BioPharma TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Aytu BioPharma?
  • What is Aytu BioPharma TTM CFF year-on-year change?

What is Aytu BioPharma annual cash flow from financing activities?

The current annual CFF of AYTU is -$1.26 M

What is the all time high annual CFF for Aytu BioPharma?

Aytu BioPharma all-time high annual cash flow from financing activities is $71.07 M

What is Aytu BioPharma annual CFF year-on-year change?

Over the past year, AYTU annual cash flow from financing activities has changed by -$10.13 M (-114.23%)

What is Aytu BioPharma quarterly cash flow from financing activities?

The current quarterly CFF of AYTU is $911.00 K

What is the all time high quarterly CFF for Aytu BioPharma?

Aytu BioPharma all-time high quarterly cash flow from financing activities is $68.18 M

What is Aytu BioPharma quarterly CFF year-on-year change?

Over the past year, AYTU quarterly cash flow from financing activities has changed by +$3.65 M (+133.32%)

What is Aytu BioPharma TTM cash flow from financing activities?

The current TTM CFF of AYTU is $2.38 M

What is the all time high TTM CFF for Aytu BioPharma?

Aytu BioPharma all-time high TTM cash flow from financing activities is $86.71 M

What is Aytu BioPharma TTM CFF year-on-year change?

Over the past year, AYTU TTM cash flow from financing activities has changed by +$9.80 M (+132.12%)